Applied DNA Sciences (NASDAQ:APDN) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of Applied DNA Sciences (NASDAQ:APDN) to a sell rating in a report issued on Tuesday morning.

Separately, HC Wainwright decreased their target price on shares of Applied DNA Sciences from $7.00 to $1.50 and set a buy rating for the company in a research report on Monday, June 10th.

Applied DNA Sciences Stock Performance

Shares of APDN opened at $1.37 on Tuesday. The company has a 50 day moving average price of $0.99 and a 200-day moving average price of $3.26. Applied DNA Sciences has a fifty-two week low of $0.31 and a fifty-two week high of $28.20. The stock has a market capitalization of $1.35 million, a PE ratio of -0.08 and a beta of 0.37.

Applied DNA Sciences (NASDAQ:APDN) last announced its quarterly earnings results on Thursday, August 8th. The technology company reported $0.47 earnings per share for the quarter, topping the consensus estimate of ($0.64) by $1.11. Applied DNA Sciences had a negative net margin of 214.42% and a negative return on equity of 138.41%. The firm had revenue of $0.80 million during the quarter, compared to analysts’ expectations of $0.95 million. During the same quarter in the prior year, the company earned ($4.80) EPS. Equities research analysts forecast that Applied DNA Sciences will post -1.8 EPS for the current year.

Institutional Investors Weigh In On Applied DNA Sciences

A hedge fund recently raised its stake in Applied DNA Sciences stock. AMH Equity Ltd boosted its position in shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) by 46.1% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 540,385 shares of the technology company’s stock after acquiring an additional 170,385 shares during the period. AMH Equity Ltd owned 63.57% of Applied DNA Sciences worth $222,000 as of its most recent filing with the Securities & Exchange Commission. 22.22% of the stock is owned by hedge funds and other institutional investors.

About Applied DNA Sciences

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.